miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications

Dysregulation of miRNAs that can act as tumor suppressors or oncogenes can result in tumorigenesis. Previously we demonstrated that miR-199b was significantly downregulated in acute myeloid leukemia (AML) and targets podocalyxin and discoidin domain receptor 1. Herein we investigated the functional...

Full description

Saved in:
Bibliographic Details
Published in:Experimental hematology & oncology 2016-02, Vol.5 (4), p.4-4, Article 4
Main Authors: Favreau, Amanda J, McGlauflin, Rose E, Duarte, Christine W, Sathyanarayana, Pradeep
Format: Article
Language:English
Subjects:
Analysis
Apoptosis
Bone marrow
Cancer
Cancer patients
DNA methylation
Epigenetics
Gene expression
Genetic aspects
Genomes
Genomics
Hematopoietic stem cells
Investigations
Kinases
Leukemia
Medical prognosis
MicroRNA
MicroRNAs
Mutation
Stem cell transplantation
Stem cells
Transplantation
Transplants & implants
Tumorigenesis
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dysregulation of miRNAs that can act as tumor suppressors or oncogenes can result in tumorigenesis. Previously we demonstrated that miR-199b was significantly downregulated in acute myeloid leukemia (AML) and targets podocalyxin and discoidin domain receptor 1. Herein we investigated the functional role of miR-199b in AML and its prognostic implications. Major approaches include transduction of hematopoietic stem cells and bone marrow transplantation, analyses of blood lineages, histone deacetylases (HDAC) inhibitors, and molecular and clinical data analyses of AML patients using The Cancer Genome Atlas (TCGA). We first examined the relative miR-199b expression in steady state hematopoiesis and showed CD33(+) myeloid progenitors had the highest miR-199b expression. Further, silencing of miR-199b in CD34(+) cells resulted in significant increases in CFU-GM colonies. Via TCGA we analyzed the molecular and clinical characteristics of 166 AML cases to investigate a prognostic role for miR-199b. The Kaplan-Meier curves for high and low expression values of miR-199b and the observed distribution of miRNA expression revealed the highly expressed group had significantly better survival outcomes (p 
ISSN:2162-3619
2162-3619
DOI:10.1186/s40164-016-0033-6